Annual SG&A:
$790.11M+$10.05M(+1.29%)Summary
- As of today, AMED annual SG&A is $790.11 million, with the most recent change of +$10.05 million (+1.29%) on December 31, 2024.
- During the last 3 years, AMED annual SG&A has risen by +$78.87 million (+11.09%).
Performance
AMED SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
Quarterly SG&A:
$0.00-$217.37M(-100.00%)Summary
- As of today, AMED quarterly SG&A is $0.00, with the most recent change of -$217.37 million (-100.00%) on June 30, 2025.
- Over the past year, AMED quarterly SG&A has dropped by -$7.83 million (-100.00%).
Performance
AMED Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
TTM SG&A:
$3.34B+$85.63M(+2.64%)Summary
- As of today, AMED TTM SG&A is $3.34 billion, with the most recent change of +$85.63 million (+2.64%) on June 30, 2025.
- Over the past year, AMED TTM SG&A has increased by +$3.10 billion (+1305.82%).
Performance
AMED TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
Selling, General & Administrative Expenses Formula
SG&A = Total Operating Expenses - Cost of Goods Sold - Research & Development
AMED Selling, General & Administrative Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1Y1 Year | +1.3% | -100.0% | +1305.8% |
3Y3 Years | +11.1% | -100.0% | +353.1% |
5Y5 Years | +30.0% | -100.0% | +414.1% |
AMED Selling, General & Administrative Expenses Highs & Lows
PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
---|---|---|---|---|---|---|---|
3Y | 3-Year | at high | +11.1% | -100.0% | at low | at high | +21.9% |
5Y | 5-Year | at high | +30.0% | -100.0% | at low | at high | +172.9% |
All-Time | All-Time | at high | >+9999.0% | -100.0% | at low | at high | +1088.3% |
AMED Selling, General & Administrative Expenses History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2025 | - | $0.00(-100.0%) | $224.10M(-3.4%) |
Mar 2025 | - | $217.37M(>+9900.0%) | $231.93M(+954.8%) |
Dec 2024 | $790.11M(+1.3%) | $0.00(-100.0%) | $21.99M(-90.7%) |
Sep 2024 | - | $6.73M(-14.1%) | $237.35M(+0.0%) |
Jun 2024 | - | $7.83M(+5.3%) | $237.24M(-46.4%) |
Mar 2024 | - | $7.43M(-96.5%) | $442.40M(-29.7%) |
Dec 2023 | $780.06M(+3.4%) | $215.36M(+3157.2%) | $629.52M(+3.6%) |
Sep 2023 | - | $6.61M(-96.9%) | $607.59M(-23.0%) |
Jun 2023 | - | $212.99M(+9.5%) | $789.32M(+3.3%) |
Mar 2023 | - | $194.56M(+0.6%) | $764.15M(+1.3%) |
Dec 2022 | $754.06M(+6.0%) | $193.43M(+2.7%) | $754.06M(+1.2%) |
Sep 2022 | - | $188.34M(+0.3%) | $745.48M(+1.3%) |
Jun 2022 | - | $187.82M(+1.8%) | $736.07M(+1.7%) |
Mar 2022 | - | $184.47M(-0.2%) | $723.47M(+1.7%) |
Dec 2021 | $711.24M(+6.4%) | $184.85M(+3.3%) | $711.24M(+1.3%) |
Sep 2021 | - | $178.93M(+2.1%) | $701.99M(-0.1%) |
Jun 2021 | - | $175.22M(+1.7%) | $702.67M(+2.8%) |
Mar 2021 | - | $172.24M(-1.9%) | $683.80M(+2.3%) |
Dec 2020 | $668.30M(+9.9%) | $175.60M(-2.2%) | $668.30M(+3.0%) |
Sep 2020 | - | $179.62M(+14.9%) | $648.77M(+4.0%) |
Jun 2020 | - | $156.34M(-0.3%) | $623.86M(+0.7%) |
Mar 2020 | - | $156.74M(+0.4%) | $619.82M(+2.0%) |
Dec 2019 | $607.93M(+21.3%) | $156.06M(+0.9%) | $607.93M(+4.1%) |
Sep 2019 | - | $154.71M(+1.6%) | $584.18M(+5.4%) |
Jun 2019 | - | $152.30M(+5.1%) | $554.01M(+5.6%) |
Mar 2019 | - | $144.85M(+9.5%) | $524.80M(+4.7%) |
Dec 2018 | $501.31M(+4.0%) | $132.32M(+6.2%) | $501.31M(+1.8%) |
Sep 2018 | - | $124.54M(+1.2%) | $492.65M(+1.2%) |
Jun 2018 | - | $123.09M(+1.4%) | $486.99M(+0.4%) |
Mar 2018 | - | $121.36M(-1.9%) | $484.82M(+0.5%) |
Dec 2017 | $482.21M(-4.2%) | $123.67M(+4.0%) | $482.21M(-0.2%) |
Sep 2017 | - | $118.88M(-1.7%) | $483.39M(-1.1%) |
Jun 2017 | - | $120.92M(+1.8%) | $488.94M(-1.2%) |
Mar 2017 | - | $118.75M(-4.9%) | $494.68M(-1.7%) |
Dec 2016 | $503.43M(+11.3%) | $124.84M(+0.3%) | $503.43M(+0.9%) |
Sep 2016 | - | $124.43M(-1.8%) | $498.85M(+2.4%) |
Jun 2016 | - | $126.66M(-0.7%) | $487.03M(+2.3%) |
Mar 2016 | - | $127.50M(+6.0%) | $475.93M(+5.2%) |
Dec 2015 | $452.44M(+2.4%) | $120.27M(+6.8%) | $452.44M(+3.7%) |
Sep 2015 | - | $112.60M(-2.6%) | $436.44M(+2.2%) |
Jun 2015 | - | $115.56M(+11.1%) | $427.01M(+1.8%) |
Mar 2015 | - | $104.01M(-0.2%) | $419.44M(-5.0%) |
Dec 2014 | $441.74M(-6.8%) | $104.27M(+1.1%) | $441.74M(-2.6%) |
Sep 2014 | - | $103.18M(-4.5%) | $453.75M(-2.7%) |
Jun 2014 | - | $107.99M(-14.5%) | $466.58M(-1.9%) |
Mar 2014 | - | $126.30M(+8.6%) | $475.54M(-0.4%) |
Dec 2013 | $474.07M(-8.2%) | $116.28M(+0.2%) | $477.65M(-3.6%) |
Sep 2013 | - | $116.01M(-0.8%) | $495.41M(-3.0%) |
Jun 2013 | - | $116.95M(-8.9%) | $510.58M(-3.6%) |
Mar 2013 | - | $128.41M(-4.2%) | $529.72M(-1.0%) |
Dec 2012 | $516.67M(+1.9%) | $134.05M(+2.2%) | $535.26M(+1.7%) |
Sep 2012 | - | $131.17M(-3.6%) | $526.20M(-1.3%) |
Jun 2012 | - | $136.08M(+1.6%) | $532.98M(+1.0%) |
Mar 2012 | - | $133.95M(+7.2%) | $527.61M(+0.2%) |
Dec 2011 | $506.81M(-6.7%) | $124.99M(-9.4%) | $526.78M(-2.9%) |
Sep 2011 | - | $137.95M(+5.5%) | $542.33M(-1.7%) |
Jun 2011 | - | $130.71M(-1.8%) | $551.54M(-2.4%) |
Mar 2011 | - | $133.13M(-5.3%) | $565.01M(-0.3%) |
Dec 2010 | $543.30M(+6.6%) | $140.54M(-4.5%) | $566.55M(+1.3%) |
Sep 2010 | - | $147.17M(+2.1%) | $559.22M(+2.8%) |
Jun 2010 | - | $144.18M(+7.1%) | $543.90M(+3.2%) |
Mar 2010 | - | $134.66M(+1.1%) | $526.98M(+2.1%) |
Dec 2009 | $509.76M | $133.22M(+1.0%) | $515.92M(+1.3%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2009 | - | $131.84M(+3.6%) | $509.26M(+2.2%) |
Jun 2009 | - | $127.26M(+3.0%) | $498.33M(+1.5%) |
Mar 2009 | - | $123.60M(-2.3%) | $490.82M(+9.7%) |
Dec 2008 | $423.28M(+71.6%) | $126.56M(+4.7%) | $447.27M(+12.7%) |
Sep 2008 | - | $120.92M(+1.0%) | $396.74M(+14.1%) |
Jun 2008 | - | $119.75M(+49.6%) | $347.85M(+17.6%) |
Mar 2008 | - | $80.06M(+5.3%) | $295.83M(+6.1%) |
Dec 2007 | $246.64M(+7.3%) | $76.03M(+5.6%) | $278.89M(+37.5%) |
Sep 2007 | - | $72.02M(+6.3%) | $202.86M(+8.3%) |
Jun 2007 | - | $67.73M(+7.3%) | $187.35M(+5.4%) |
Mar 2007 | - | $63.11M(>+9900.0%) | $177.71M(+4.0%) |
Dec 2006 | $229.93M(+36.5%) | $0.00(-100.0%) | $170.92M(-24.2%) |
Sep 2006 | - | $56.51M(-2.7%) | $225.45M(+4.4%) |
Jun 2006 | - | $58.08M(+3.1%) | $215.94M(+12.4%) |
Mar 2006 | - | $56.32M(+3.3%) | $192.16M(+15.6%) |
Dec 2005 | $168.42M(+72.5%) | $54.54M(+16.0%) | $166.30M(+20.2%) |
Sep 2005 | - | $47.00M(+37.1%) | $138.34M(+19.5%) |
Jun 2005 | - | $34.30M(+12.6%) | $115.74M(+8.5%) |
Mar 2005 | - | $30.46M(+14.6%) | $106.64M(+9.8%) |
Dec 2004 | $97.63M(+40.3%) | $26.58M(+8.9%) | $97.13M(+8.4%) |
Sep 2004 | - | $24.40M(-3.2%) | $89.60M(+7.7%) |
Jun 2004 | - | $25.20M(+20.3%) | $83.16M(+11.6%) |
Mar 2004 | - | $20.95M(+10.0%) | $74.50M(+7.1%) |
Dec 2003 | $69.58M(+10.3%) | $19.05M(+6.1%) | $69.58M(+27.4%) |
Sep 2003 | - | $17.96M(+8.6%) | $54.61M(+4.5%) |
Jun 2003 | - | $16.54M(+3.1%) | $52.24M(+2.4%) |
Mar 2003 | - | $16.04M(+293.5%) | $51.02M(+2.1%) |
Dec 2002 | $63.06M(+17.5%) | $4.08M(-73.8%) | $49.97M(+1.0%) |
Sep 2002 | - | $15.59M(+1.8%) | $49.49M(+3.2%) |
Jun 2002 | - | $15.32M(+2.2%) | $47.96M(+4.5%) |
Mar 2002 | - | $14.99M(+316.2%) | $45.88M(+4.1%) |
Dec 2001 | $53.66M(+9.0%) | $3.60M(-74.4%) | $44.07M(+8.9%) |
Sep 2001 | - | $14.06M(+6.2%) | $40.47M(+53.2%) |
Jun 2001 | - | $13.23M(+0.4%) | $26.41M(+100.4%) |
Mar 2001 | - | $13.18M(>+9900.0%) | $13.18M(>+9900.0%) |
Dec 2000 | $49.25M(-7.3%) | $0.00(0.0%) | $0.00(0.0%) |
Sep 2000 | - | $0.00(0.0%) | $0.00(0.0%) |
Jun 2000 | - | $0.00(0.0%) | $0.00(0.0%) |
Mar 2000 | - | $0.00(0.0%) | $0.00(0.0%) |
Dec 1999 | $53.15M(+58.6%) | $0.00(0.0%) | $0.00(0.0%) |
Sep 1999 | - | $0.00(0.0%) | $0.00(0.0%) |
Jun 1999 | - | $0.00(0.0%) | $0.00(0.0%) |
Mar 1999 | - | $0.00(0.0%) | $0.00(0.0%) |
Dec 1998 | $33.51M(+37.1%) | $0.00(0.0%) | $0.00(-100.0%) |
Sep 1998 | - | $0.00(0.0%) | $10.24M(-34.1%) |
Jun 1998 | - | $0.00(0.0%) | $15.54M(-24.7%) |
Mar 1998 | - | $0.00(-100.0%) | $20.64M(-19.2%) |
Dec 1997 | $24.44M(+32.0%) | $10.24M(+93.3%) | $25.54M(+25.1%) |
Sep 1997 | - | $5.30M(+3.9%) | $20.41M(+3.0%) |
Jun 1997 | - | $5.10M(+4.1%) | $19.81M(+2.6%) |
Mar 1997 | - | $4.90M(-4.1%) | $19.31M(+4.3%) |
Dec 1996 | $18.51M(+34.1%) | $5.11M(+8.8%) | $18.51M(+5.8%) |
Sep 1996 | - | $4.70M(+2.2%) | $17.50M(+6.1%) |
Jun 1996 | - | $4.60M(+12.2%) | $16.50M(+9.3%) |
Mar 1996 | - | $4.10M(0.0%) | $15.10M(+11.0%) |
Dec 1995 | $13.80M(+62.4%) | $4.10M(+10.8%) | $13.60M(+43.2%) |
Sep 1995 | - | $3.70M(+15.6%) | $9.50M(+63.8%) |
Jun 1995 | - | $3.20M(+23.1%) | $5.80M(+20.8%) |
Mar 1995 | - | $2.60M(+18.2%) | $4.80M(+17.1%) |
Dec 1994 | $8.50M(+80.9%) | - | - |
Jun 1994 | - | $2.20M(+15.8%) | $4.10M(+115.8%) |
Mar 1994 | - | $1.90M | $1.90M |
Dec 1993 | $4.70M | - | - |
FAQ
- What is Amedisys, Inc. annual SG&A?
- What is the all-time high annual SG&A for Amedisys, Inc.?
- What is Amedisys, Inc. annual SG&A year-on-year change?
- What is Amedisys, Inc. quarterly SG&A?
- What is the all-time high quarterly SG&A for Amedisys, Inc.?
- What is Amedisys, Inc. quarterly SG&A year-on-year change?
- What is Amedisys, Inc. TTM SG&A?
- What is the all-time high TTM SG&A for Amedisys, Inc.?
- What is Amedisys, Inc. TTM SG&A year-on-year change?
What is Amedisys, Inc. annual SG&A?
The current annual SG&A of AMED is $790.11M
What is the all-time high annual SG&A for Amedisys, Inc.?
Amedisys, Inc. all-time high annual SG&A is $790.11M
What is Amedisys, Inc. annual SG&A year-on-year change?
Over the past year, AMED annual SG&A has changed by +$10.05M (+1.29%)
What is Amedisys, Inc. quarterly SG&A?
The current quarterly SG&A of AMED is $0.00
What is the all-time high quarterly SG&A for Amedisys, Inc.?
Amedisys, Inc. all-time high quarterly SG&A is $217.37M
What is Amedisys, Inc. quarterly SG&A year-on-year change?
Over the past year, AMED quarterly SG&A has changed by -$7.83M (-100.00%)
What is Amedisys, Inc. TTM SG&A?
The current TTM SG&A of AMED is $3.34B
What is the all-time high TTM SG&A for Amedisys, Inc.?
Amedisys, Inc. all-time high TTM SG&A is $3.34B
What is Amedisys, Inc. TTM SG&A year-on-year change?
Over the past year, AMED TTM SG&A has changed by +$3.10B (+1305.82%)